BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8359105)

  • 1. Acute insulin response to glucose and glucagon in subjects at risk of developing type I diabetes.
    Vialettes B; Zevaco-Mattei C; Thirion X; Lassmann-Vague V; Pieron H; Mercier P; Vague P
    Diabetes Care; 1993 Jul; 16(7):973-7. PubMed ID: 8359105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of metabolic progression to type I diabetes in ICA+ relatives of patients with type I diabetes.
    Bleich D; Jackson RA; Soeldner JS; Eisenbarth GS
    Diabetes Care; 1990 Feb; 13(2):111-8. PubMed ID: 2190768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet cell antibodies and beta-cell function in gestational diabetic women: comparison to first-degree relatives of type 1 (insulin-dependent) diabetic subjects.
    Mauricio D; Corcoy R; Codina M; Morales J; Balsells M; de Leiva A
    Diabet Med; 1995 Nov; 12(11):1009-14. PubMed ID: 8582122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients.
    Vardi P; Crisa L; Jackson RA
    Diabetologia; 1991 Feb; 34(2):93-102. PubMed ID: 2065854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of progression to diabetes of low titer ICA-positive first-degree relatives of type I diabetics in southern Germany.
    Ziegler AG; Baumgartl HJ; Standl E; Mehnert H
    J Autoimmun; 1990 Oct; 3(5):619-24. PubMed ID: 2252530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.
    Gottsäter A; Landin-Olsson M; Fernlund P; Lernmark A; Sundkvist G
    Diabetes Care; 1993 Jun; 16(6):902-10. PubMed ID: 8325204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between first-phase insulin secretion and age, HLA, islet cell antibody status, and development of type I diabetes in 220 juvenile first-degree relatives of diabetic patients.
    Robert JJ; Deschamps I; Chevenne D; Roger M; Mogenet A; Boitard C
    Diabetes Care; 1991 Aug; 14(8):718-23. PubMed ID: 1954807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes.
    Gianani R; Pugliese A; Bonner-Weir S; Shiffrin AJ; Soeldner JS; Erlich H; Awdeh Z; Alper CA; Jackson RA; Eisenbarth GS
    Diabetes; 1992 Mar; 41(3):347-53. PubMed ID: 1551494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of human cytoplasmic islet-cell antibodies which cross-react with mouse pancreas: a follow-up study in type 1 (insulin-dependent) diabetic patients and in first-degree relatives.
    Saï P; Elmansour A; Audrain M; Charbonnel B; Bardet S
    Diabetologia; 1993 Aug; 36(8):778-84. PubMed ID: 8405747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of age-related acute insulin response to glucose in subjects at risk for type 1 diabetes: results of a 6-year follow-up study from west-France.
    Bardet S; Joseph MG; Maugendre D; Matthieu E; Chaillous L; Semana G; Limal JM; Allannic H; Charbonnel B; Sai P
    Diabete Metab; 1993; 19(4):372-80. PubMed ID: 8293864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High proinsulin levels in late PRE-IDDM stage.
    Rodríguez-Villar C; Conget I; Casamitjana R; Vidal J; Manzanares JM; Gomis R
    Diabetes Res Clin Pract; 1997 Aug; 37(2):145-8. PubMed ID: 9279485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute insulin response to intravenous glucose, glucagon and arginine in some subjects at risk for type 1 (insulin-dependent) diabetes mellitus.
    Bardet S; Rohmer V; Maugendre D; Marre M; Semana G; Limal JM; Allannic H; Charbonnel B; Saï P
    Diabetologia; 1991 Sep; 34(9):648-54. PubMed ID: 1955097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Decrease of early insulin secretion, risk factor of insulin-dependent diabetes. Prospective study in families with diabetic children].
    Robert JJ; Boitard C; Mogenet A; Chevenne D; Roger M; Deschamps I
    Arch Fr Pediatr; 1991 Jan; 48(1):11-7. PubMed ID: 2018414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased insulin response to glucose in islet cell antibody-negative siblings of type 1 diabetic children.
    Carel JC; Boitard C; Bougnères PF
    J Clin Invest; 1993 Jul; 92(1):509-13. PubMed ID: 8326015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
    Füchtenbusch M; Rabl W; Grassl B; Bachmann W; Standl E; Ziegler AG
    Diabetologia; 1998 May; 41(5):536-41. PubMed ID: 9628270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired insulin secretion in non-diabetic offspring of probands with latent autoimmune diabetes mellitus in adults.
    Vauhkonen I; Niskanen L; Knip M; Ilonen J; Vanninen E; Kainulainen S; Uusitupa M; Laakso M
    Diabetologia; 2000 Jan; 43(1):69-78. PubMed ID: 10663218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
    Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
    Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of islet cell antibodies among 1021 relatives of type 1 diabetics].
    Maiz A; Manrique M; Hodgson MI; Díaz de Valdés M; Acosta AM; Andrade L; Olmos P
    Rev Med Chil; 1999 May; 127(5):515-22. PubMed ID: 10451620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study.
    Greenbaum CJ; Sears KL; Kahn SE; Palmer JP
    Diabetes; 1999 Jan; 48(1):170-5. PubMed ID: 9892239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.